Ixekizumab May Improve Renal Function in Psoriasis.
Healthcare (Basel)
; 9(5)2021 May 07.
Article
in English
| MEDLINE | ID: covidwho-1256477
ABSTRACT
BACKGROUND:
Psoriasis is a chronic dermatological condition characterized by lesions on extensor surfaces, hands, feet, and genital areas. Chronic renal failure is often associated with metabolic syndrome and inflammatory conditions, such as psoriasis. CASE REPORT In this paper, we report a patient with stage-three chronic renal failure that improved his renal condition after treatment with ixekizumab, an anti-IL17A drug used in the treatment of various cutaneous and rheumatological conditions.CONCLUSIONS:
IL17A blockage may help to treat various autoimmune and inflammatory conditions, such as psoriasis, that may lead to renal impairment. Further investigation is necessary in order to prove the effectiveness of this drug in renal conditions.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Language:
English
Year:
2021
Document Type:
Article
Affiliation country:
Healthcare9050543
Similar
MEDLINE
...
LILACS
LIS